Tacrolimus monotherapy: a promising option for ocular myasthenia gravis

Eur Neurol. 2013;69(6):344-5. doi: 10.1159/000347068. Epub 2013 Mar 19.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Aged, 80 and over
  • Female
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Male
  • Middle Aged
  • Myasthenia Gravis / drug therapy*
  • Retrospective Studies
  • Tacrolimus / therapeutic use*
  • Treatment Outcome

Substances

  • Immunosuppressive Agents
  • Tacrolimus